Clinical Trial to Assess the Efficacy and Safety of INNOCELL Immuncell-LC With Temozolomide in Newly Diagnosed Glioblastoma of Korea

針對症狀 Glioblastoma
臨床試驗編號 NCT00807027
臨床階段 Phase III
臨床試驗位址 7 Study Locations
目前研究進度 This study has been completed.
試驗開始日期 December 10, 2008
試驗開始日期 October 24, 2012
臨床目的 This clinical study was planned in order to assess the superiority of INNOCELL Corp. "Immuncell-LC" in aspects of therapeutic efficacy and safety when administered with Temozolomide to glioblastoma patients when compared with the control group who did not receive administration of the drug.